These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 23612198

  • 1. Appropriateness of empirical treatment and outcome in bacteremia caused by extended-spectrum-β-lactamase-producing bacteria.
    Frakking FN, Rottier WC, Dorigo-Zetsma JW, van Hattem JM, van Hees BC, Kluytmans JA, Lutgens SP, Prins JM, Thijsen SF, Verbon A, Vlaminckx BJ, Cohen Stuart JW, Leverstein-van Hall MA, Bonten MJ.
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3092-9. PubMed ID: 23612198
    [Abstract] [Full Text] [Related]

  • 2. Should we consider faecal colonisation with extended-spectrum β-lactamase-producing Enterobacteriaceae in empirical therapy of community-onset sepsis?
    Stupica D, Lusa L, Klevišar MN, Terzić S, Pirš M, Premru MM, Strle F.
    Int J Antimicrob Agents; 2017 Oct; 50(4):564-571. PubMed ID: 28711676
    [Abstract] [Full Text] [Related]

  • 3. Impact of appropriateness of empiric therapy on outcomes in community-onset bacteremia by extended-spectrum-β-lactamase producing Escherichia coli and Klebisella pneumoniae definitively treated with carbapenems.
    Joo EJ, Park DA, Lee NR, Moon SY, Choi JK, Ko JH, Peck KR.
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2093-2100. PubMed ID: 28643188
    [Abstract] [Full Text] [Related]

  • 4. Associated factors and clinical outcomes of bloodstream infection due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae during febrile neutropenia.
    Ben-Chetrit E, Eldaim MA, Bar-Meir M, Dodin M, Katz DE.
    Int J Antimicrob Agents; 2019 Apr; 53(4):423-428. PubMed ID: 30572008
    [Abstract] [Full Text] [Related]

  • 5. Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy.
    Kang CI, Chung DR, Ko KS, Peck KR, Song JH, Korean Network for Study of Infectious Diseases.
    Ann Hematol; 2012 Jan; 91(1):115-21. PubMed ID: 21556875
    [Abstract] [Full Text] [Related]

  • 6. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K, Wong SS, Lin LC, Tsai CR, Chen LC, Huang CH.
    J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
    [Abstract] [Full Text] [Related]

  • 7. Nosocomial extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteremia in hemodialysis patients and the implications for antibiotic therapy.
    Yang CC, Wu CH, Lee CT, Liu HT, Chen JB, Chiu CH, Chen CH, Chuang FR.
    Int J Infect Dis; 2014 Nov; 28():3-7. PubMed ID: 25200093
    [Abstract] [Full Text] [Related]

  • 8. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
    Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW.
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4574-81. PubMed ID: 15561828
    [Abstract] [Full Text] [Related]

  • 9. [Mortality risk factors for bloodstream infections caused by extended-spectrum beta-lactamase-producing microorganisms].
    Ferrández O, Grau S, Saballs P, Luque S, Terradas R, Salas E.
    Rev Clin Esp; 2011 Mar; 211(3):119-26. PubMed ID: 21371702
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
    Cordery RJ, Roberts CH, Cooper SJ, Bellinghan G, Shetty N.
    J Hosp Infect; 2008 Feb; 68(2):108-15. PubMed ID: 18063198
    [Abstract] [Full Text] [Related]

  • 11. Carbapenem therapy for bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli or Klebsiella pneumoniae: implications of ertapenem susceptibility.
    Lee NY, Lee CC, Huang WH, Tsui KC, Hsueh PR, Ko WC.
    Antimicrob Agents Chemother; 2012 Jun; 56(6):2888-93. PubMed ID: 22430969
    [Abstract] [Full Text] [Related]

  • 12. Influence of Antimicrobial Stewardship and Molecular Rapid Diagnostic Tests on Antimicrobial Prescribing for Extended-Spectrum Beta-Lactamase- and Carbapenemase-Producing Escherichia coli and Klebsiella pneumoniae in Bloodstream Infection.
    Kunz Coyne AJ, Casapao AM, Isache C, Morales J, McCarter YS, Jankowski CA.
    Microbiol Spectr; 2021 Oct 31; 9(2):e0046421. PubMed ID: 34704795
    [Abstract] [Full Text] [Related]

  • 13. Epidemiology and clinical features of community-onset bacteremia caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae.
    Lee JA, Kang CI, Joo EJ, Ha YE, Kang SJ, Park SY, Chung DR, Peck KR, Ko KS, Lee NY, Song JH.
    Microb Drug Resist; 2011 Jun 31; 17(2):267-73. PubMed ID: 21388296
    [Abstract] [Full Text] [Related]

  • 14. [Bacteremia caused by Escherichia coli and Klebsiella pneumoniae producing extended-spectrum betalactamases: mortality and readmission-related factors].
    Perianes-Díaz ME, Novo-Veleiro I, Solís-Díaz K, Prolo-Acosta A, García-García I, Alonso-Claudio G.
    Med Clin (Barc); 2014 May 06; 142(9):381-6. PubMed ID: 23735867
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Bacteremic pneumonia caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: Appropriateness of empirical treatment matters.
    Cheng WL, Hsueh PR, Lee CC, Li CW, Li MJ, Chang CM, Lee NY, Ko WC.
    J Microbiol Immunol Infect; 2016 Apr 06; 49(2):208-15. PubMed ID: 25070279
    [Abstract] [Full Text] [Related]

  • 20. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.
    Tumbarello M, Sanguinetti M, Montuori E, Trecarichi EM, Posteraro B, Fiori B, Citton R, D'Inzeo T, Fadda G, Cauda R, Spanu T.
    Antimicrob Agents Chemother; 2007 Jun 06; 51(6):1987-94. PubMed ID: 17387156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.